<?xml version="1.0" encoding="UTF-8"?>
<records>
<record>
<language>eng</language>
<publisher>Science and Education Publishing</publisher>
<journalTitle>American Journal of Public Health Research</journalTitle>
<eissn>2327-6703</eissn>
<publicationDate>2022-03-31</publicationDate>
<volume>10</volume>
<issue>2</issue>
<startPage>76</startPage>
<endPage>89</endPage>
<doi>10.12691/ajphr-10-2-5</doi>
<publisherRecordId>AJPHR20221025</publisherRecordId>
<documentType>article</documentType>
<title language="eng">Factors Associated with Uptake of Isoniazid Preventive Therapy among Children under 5 Years Tuberculosis Contacts in Greater Kibaale, Uganda</title>
<authors>
<author>
<name>Tenywa Isaac</name>
<affiliationId>1</affiliationId>
</author>
<author>
<name>Omona Kizito</name>
<email>komona@umu.ac.ug</email>
<affiliationId>2</affiliationId>
</author>

</authors>
<affiliationsList>
<affiliationName affiliationId="1">MPH Specialist, Faculty of Health Sciences, Uganda Martyrs University</affiliationName>
<affiliationName affiliationId="2">Lecturer, Faculty of Health Sciences, Uganda Martyrs University</affiliationName>
</affiliationsList>
<abstract language="eng">Isoniazid Preventive Therapy (IPT) is a chemoprophylaxis which reduces the risk of the first episode of TB occurring in people exposed to an infection or with latent infection and the risk of a recurrent episode of TB. WHO recommends isoniazid taken at a daily dose of 5 mg/kg (maximum 300 mg) for at least six months. In Uganda, only 16% of 15957 children contacts of smear-positive TB index cases are on preventive treatment.&#160;The objective of this study was to assess factors associated with uptake of isoniazid preventive therapy among children under 5 years¡¯ tuberculosis contacts in Greater Kibaale.&#160;An analytical&#160;cross-sectional study design&#160;utilizing both quantitative and qualitative methods was conducted among 207 children under 5 years¡¯ tuberculosis contacts. They were recruited using convenience sampling methods. The caregiver of the children completed a structured questionnaire in English and translated into Lunyoro.&#160;Data was single-entered and analyzed using SPSS version 22. Bivariate, univariate and multivariate Logistic regression analysis methods were used to identify factors associated with uptake of isoniazid preventive.&#160;Of the 207 participants, the uptake IPT was low at 36.7%. Being in the age group of 35-44 years (AOR=15.856, 95% CI: 11.568-27.115), being married, AOR=17.867, 95% CI: 4.631-215.769), p=.008) being separated (AOR=4.4.35, 95% CI; 1.056-6.530, p=0.047), having a monthly income of 40,000-100,000 shillings (AOR=9.917, 95% CI: 6.380-15.450, p=.000), finding it easy to talk to other people about TB problem AOR=.012, 95% CI: .004-.303, p=.007), not screening for TB (AOR=0.391, 95% CI: .242-.791, p=.000) and receiving continuous counselling (AOR=0.004, 95% CI: .001-.142, p=.002) were independently associated with uptake of isoniazid preventive.&#160;Conclusively, the level of uptake of IPT was low. Contact screening seems a good entry point for delivery of Isoniazid Preventive Therapy to at-risk children when routinely practised as recommended by WHO.</abstract>
<fullTextUrl format="pdf">http://pubs.sciepub.com/ajphr/10/2/5/ajphr-10-2-5.pdf</fullTextUrl>
<keywords language="eng"><keyword>Isoniazid Preventive Therapy (IPT)</keyword>
<keyword>Tuberculosis (TB)</keyword>
<keyword>health care</keyword>
<keyword>barriers</keyword>
<keyword>facilitators</keyword>
<keyword>quality of care</keyword>
</keywords>
</record>
</records>
